While members of Congress are increasingly involved in various stock purchases, data indicates they are particularly focused on two equities.
Indeed, these Congress trades have raised eyebrows, especially given recent fundamental shifts and concerns over the potential use of insider information.
Receive Signals on US Congress Members' Stock Trades
Stay up-to-date on the trading activity of US Congress members. The signal triggers based on updates from the House disclosure reports, notifying you of their latest stock transactions.
According to data from Ganify, here are the two equities lawmakers are heavily investing in:
Advanced Micro Devices (NASDAQ: AMD)
Ganify’s data shows that congressional trading activity in Advanced Micro Devices (NASDAQ: AMD) has been active yet balanced over the past three months.
Notably, purchases peaked 15 to 18 months ago at $198,500, while sales during that same period reached $84,500.
More recently, buying has surged to $347,000, with sales at $282,500 in the last three months. This indicates lawmakers’ strong interest in the semiconductor giant, likely fueled by the global demand for AI chips.
Among the most active traders is House Representative Marjorie Taylor Greene, who has executed several AMD purchases at varying amounts in recent months.
These buys come amid a challenging 2025 for AMD, with the stock down nearly 9% year to date, trading at $110 as of the last close.
UnitedHealth (NYSE: UNH)
UnitedHealth (NYSE: UNH) has also seen significant congressional activity. The stock experienced $746,000 in sales 12 to 15 months ago, while purchases have remained steady, totaling $336,000 15 to 18 months ago and $194,500 in the last three months.
Greene is also among the lawmakers who have recently accumulated UNH stock, coinciding with heightened uncertainty surrounding the company. Other lawmakers who have accumulated UNH shares in the last three months include John McGuire, John Boozman, and Michael McCaul.
Finbold reported that UnitedHealth recently underwent a historic free fall following a leadership change and suspension of its 2025 guidance. However, the stock has since rebounded, boosted by a wave of insider buying.
Before the sell-off, some lawmakers had already offloaded shares, raising questions about possible foreknowledge of the company’s troubles.
Meanwhile, Wall Street remains cautious on UNH, citing leadership instability and a lack of guidance. As of press time, UNH shares were trading at $295.57, down over 40% year to date.
For investors eyeing these stocks, it’s worth noting that congressional trades have sometimes outperformed the market, potentially due to policymakers’ access to early insights on legislation or economic shifts.
However, this activity doesn’t guarantee success. Both stocks face risks tied to their industries and broader market conditions.
Featured image via Shutterstock
